CID 155035

4-l-proline-7-(4-hydroxy-l-leucine)phalloidin

Structural Information

Molecular Formula
C35H48N8O9S
SMILES
CC1C(=O)NC2CC3=C(NC4=CC=CC=C34)SCC(C(=O)N5CCCC5C(=O)N1)NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CC(C)(C)O)C)C(C)O
InChI
InChI=1S/C35H48N8O9S/c1-16-27(45)38-22-13-20-19-9-6-7-10-21(19)41-33(20)53-15-24(34(51)43-12-8-11-25(43)31(49)37-16)40-32(50)26(18(3)44)42-28(46)17(2)36-30(48)23(39-29(22)47)14-35(4,5)52/h6-7,9-10,16-18,22-26,41,44,52H,8,11-15H2,1-5H3,(H,36,48)(H,37,49)(H,38,45)(H,39,47)(H,40,50)(H,42,46)
InChIKey
VXROMVCOGJAUJL-UHFFFAOYSA-N
Compound name
34-(1-hydroxyethyl)-28-(2-hydroxy-2-methylpropyl)-23,31-dimethyl-12-thia-10,16,22,25,27,30,33,36-octazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraene-15,21,24,26,29,32,35-heptone
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

13
Patents

756.3265 Da
Monoisotopic Mass

0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 757.33378 276.8
[M+Na]+ 779.31572 282.7
[M-H]- 755.31922 262.1
[M+NH4]+ 774.36032 273.0
[M+K]+ 795.28966 261.9
[M+H-H2O]+ 739.32376 246.0
[M+HCOO]- 801.32470 273.8
[M+CH3COO]- 815.34035 276.6
[M+Na-2H]- 777.30117 260.5
[M]+ 756.32595 279.8
[M]- 756.32705 279.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe